• Products
  • Insights
  • Practice Management
  • Resources
  • About Us

Domestic Equity fund

Hartford Healthcare Fund   

SHARE CLASS
NAV
$46.28
NAV CHANGE
Key Documents
      Actions

      Domestic Equity fund

      Hartford Healthcare Fund   
      Share Class - R6 (HGHVX)

      Opportunistic

       

      Seeks to capitalize on the demographics, globalization, and innovation opportunities in the global-health care market

      Best Ideas

       

      Uses in-depth research to create a portfolio with the best ideas from portfolio managers and analysts

      Sub-advised by Wellington

       

      Wellington prioritizes independent thought and collaboration across all major asset classes

      Objective: Seeks long-term capital appreciation.

      Portfolio Management
      Rebecca Sykes, CFA
      Senior Managing Director
      Global Industry Analyst
      5
      YRS
      MANAGING THIS FUND
      18
      YRS
      AT WELLINGTON MANAGEMENT
      20
      YRS
      EXPERIENCE IN THIS INDUSTRY

      The portfolio manager is supported by the full resources of Wellington.

      Performance

      PERFORMANCE %
       
      CUMULATIVE %
      (as of 9/30/2025)
      AVERAGE ANNUAL TOTAL RETURNS %
      (as of 9/30/2025)
      YTD 1YR 3YR 5YR 10YR SI
      Hartford Healthcare R6 0.51 -11.16 5.21 2.56 7.44 10.42
      Benchmark 2.21 -7.83 6.33 7.08 9.59 ---
      Morningstar Health Category 6.52 -2.72 6.30 2.76 6.96 ---
       
      CUMULATIVE %
      (as of 9/30/2025)
      AVERAGE ANNUAL TOTAL RETURNS %
      (as of 9/30/2025)
      YTD 1YR 3YR 5YR 10YR SI
      Hartford Healthcare R6 0.51 -11.16 5.21 2.56 7.44 10.42
      Benchmark 2.21 -7.83 6.33 7.08 9.59 ---
      Morningstar Health Category 6.52 -2.72 6.30 2.76 6.96 ---

      Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

      SI = Since Inception. Fund Inception: 05/01/2000

      Fund Inception: 5/1/00. Share Class Inception: 2/28/19.
      Class R6-share performance prior to 2/28/19 reflects the performance and operating expenses of Class Y-shares. Performance for Class R6 shares prior to its inception date would have differed if the operating expenses of Class R6 had been reflected. SI performance is calculated from 5/1/00.

      Hartford Healthcare Fund R6 Share Morningstar Ratings
      Morningstar Medalist RatingTM
      9/23/2025
      The Fund’s Class R6 shares have not been in operation for 10 years. Therefore, the Calendar Year Returns (R6 Shares) chart includes performance and operating expenses of another class. For more information, see the prospectus.

      Characteristics

      FUND ESSENTIALS (as Of 10/30/2025)
      Inception Date 05/01/2000
      Net Assets $768 million
      Total Operating Expenses 0.92%
      Morningstar Category Health
      Lipper Classification Health/Biotechnology Funds
      CUSIP 41665K436
      Fund Number 1738
      FUND STATS (as of 9/30/2025)
      # of Holdings
      		79
      % in Equities
      		99
      % in Foreign Equities
      		10
      Beta (3 year)
      		0.98
      R Squared (3 year)
      		0.93
      Standard Deviation
      		13.94%
      Turnover
      		43%
      Active Share
      		41%
      Holdings Characteristics (as of 9/30/2025)
      FUND S&P Composite 1500 Health Care Index
      Price/Earnings
      		25.1x 16.2x
      Price/Book
      		5.2x 4.7x
      EPS Growth Rate
      		7.2% 7.4%
      Asset Weighted Market Cap (billions)
      		$206.0 $234.8
      Return on Equity
      		20.7% 32.9%
      Median Market Cap (billions)
      		$10.1 $7.5
      Regional Exposure (%)
      North America 90
      Developed EU & Middle East ex UK 6
      United Kingdom 3
      Japan 1
      Emerging Markets 0
      North America 90
      Developed EU & Middle East ex UK 6
      United Kingdom 3
      Japan 1
      Emerging Markets 0
      Top Ten Holdings (%) (as of 9/30/2025)
      Eli Lilly & Co. 12.04
      UnitedHealth Group, Inc. 5.95
      AbbVie, Inc. 4.73
      Johnson & Johnson 4.48
      Merck & Co., Inc. 4.19
      Boston Scientific Corp. 3.42
      Intuitive Surgical, Inc. 3.22
      Vertex Pharmaceuticals, Inc. 3.07
      Edwards Lifesciences Corp. 2.97
      Cencora, Inc. 2.90
      Total Portfolio % 46.97

      Full Portfolio Holdings

      Market Cap Distribution (%) (as of 9/30/2025)

      Market Cap Header3
      Less than $2 billion 3
      $2 billion - $5 billion 9
      $5 billion - $10 billion 5
      Greater than $10 billion 83
      Not Classified 0
      RETURN CHARACTERISTICS (as of 9/30/25)
      Alpha (5 Year)
      		-4.25
      Down Capture (5 Year)
      		107.22
      Information Ratio (5 Year)
      		-1.00
      Sharpe Ratio (5 Year)
      		0.02
      Up Capture (5 Year)
      		87.61
      Subsector Exposure (%)
      Biopharma Large Cap 40
      Medical Technology 26
      Health Care Services 18
      Biopharma Mid Cap 13
      Biopharma Small Cap 3
      Biopharma Large Cap 40
      Medical Technology 28
      Health Care Services 22
      Biopharma Mid Cap 8
      Biopharma Small Cap 1
      Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.
      distributions and capital gains
      Distribution Date Distribution NAV ordinary income short term capital gains long term capital gains total distribution
      12/27/2024 43.84 $0.2102 $0.0000 $0.0000 $0.2102
      12/11/2024 45.43 $0.0000 $0.6470 $1.2516 $1.8986
      Past distributions are not indicative of future distributions.

      Resources

      Literature
      Fact Sheet
      Expanded Commentary
      Commentary
      Pitchbook
      Regulatory Documents
      Summary Prospectus
      Statutory Prospectus
      Statement of Additional Information (SAI)
      Financial Statements and Other Information – Semi-Annual
      Financial Statements and Other Information – Annual
      Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, changes in funding or subsidies, patent and intellectual property considerations, intense competitive pressures, rapid technological changes, long and costly process for obtaining product approval by government agencies, potential product obsolescence, rising cost of medical products and services, and price volatility risk. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities. • The securities of large market capitalization companies may underperform other segments of the market. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political, economic and regulatory developments.
      4517824